Literature DB >> 6806524

[New aspects of the blood flow-augmenting and insulin-like activity of muscle exercise: possible involvement of the kallikrein-kinin-prostaglandin system (author's transl)].

G Dietze.   

Abstract

Adaptations of energy metabolism, as they occur during contractions of skeletal muscle besides by anaerobic glycolysis are achieved via changes in capillary blood flow providing substrates and oxygen for combustion. Since, initially, oxygen supply is restricted in the working muscle, glucose would seem to be the adequate fuel as it may be used anaerobically and yields more energy per mole of oxygen than fatty acids under such circumstances. Besides glucose, amino acids are also required for accelerated proteosynthesis according to the work load. Therefore, an enlargement of the capillary net has to be accompanied by an amplification of the action of insulin, which is often present in only small amounts, e.g., after an overnight fast. This aim is met in three ways: (1) enlargement of the capillary net with accelerated blood flow increasing the supply of insulin and the number of receptor sites for insulin binding; (2) accelerated transport of insulin through the capillary wall, providing more insulin in the interstitial space and at the plasma membranes; (3) a molecular mechanism directly involving the insulin-receptor-messenger complex, localized at the plasma membrane of the working muscle cell. These mechanisms resemble a self-regulatory process, set in motion by the release of metabolites from the working tissue. From recent studies there is accumulating evidence that kinins liberated from their precursors are involved as tissue hormones by carrying the signal across the interstitial space to the smooth muscle cells of the capillary vessels. Concomitantly, prostaglandins are released intracellularly to bring about, in cooperation with kinins, the various adaptive mechanisms. Amplifying systems of this kind may play a role not only in muscle but also in other tissues where adequate kinin or prostaglandin release would appear beneficial under several clinical conditions such as shock, coronary infarction, wound healing, etc.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806524     DOI: 10.1007/BF01720357

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  124 in total

1.  A MUSCLE ACTIVITY FACTOR INCREASING SUGAR UPTAKE BY RAT DIAPHRAGMS IN VITRO.

Authors:  E HAVIVI; H E WERTHEIMER
Journal:  J Physiol       Date:  1964-08       Impact factor: 5.182

2.  Role of the nervous system in the control of vascular tone.

Authors:  B FOLKOW
Journal:  Circulation       Date:  1960-05       Impact factor: 29.690

3.  The Changes of the Blood-stream in Muscles through Stimulation of their Nerves.

Authors:  W H Gaskell
Journal:  J Anat Physiol       Date:  1877-04

4.  Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin.

Authors:  M ROCHA E SILVA; W T BERALDO; G ROSENFELD
Journal:  Am J Physiol       Date:  1949-02

5.  [Effect of bradykinin on muscular glucose uptake in man (author's transl)].

Authors:  G Dietze; M Wicklmayr
Journal:  Klin Wochenschr       Date:  1977-04-01

6.  Role of tissue hyperosmolality in exercise hyperemia.

Authors:  S Mellander; J Lundvall
Journal:  Circ Res       Date:  1971-01       Impact factor: 17.367

7.  Evidence for an involvement of kinin liberation in the priming action of insulin on glucose uptake into skeletal muscle.

Authors:  M Wicklmayr; G Dietze; L Mayer; I Böttger; J Grunst
Journal:  FEBS Lett       Date:  1979-02-01       Impact factor: 4.124

8.  Blood bradykinin levels in the human.

Authors:  R Zacest; M L Mashford
Journal:  Aust J Exp Biol Med Sci       Date:  1967-02

9.  Anoxia-induced release of prostaglandins in rabbit isolated hearts.

Authors:  A J Block; H Feinberg; K Herbaczynska-Cedro; J R Vane
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

10.  Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart.

Authors:  R W Alexander; K M Kent; J J Pisano; H R Keiser; T Cooper
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

View more
  2 in total

Review 1.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

2.  [Effect of prostaglandin E1 on amino acid metabolism of human skeletal muscle].

Authors:  H Stiegler; M Wicklmayr; K Rett; H Mehnert
Journal:  Klin Wochenschr       Date:  1990-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.